Cargando…
Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion
BACKGROUND: Critical organ shortage results in the utilization of extended donor criteria (EDC) liver grafts. These marginal liver grafts are prone to increased ischemia reperfusion injury (IRI) which may contribute to deteriorated graft function and survival. Experimental data have shown that the c...
Autores principales: | Pratschke, Sebastian, Eder, Michael, Heise, Michael, Nadalin, Silvio, Pascher, Andreas, Schemmer, Peter, Scherer, Marcus N, Ulrich, Frank, Wolters, Heiner, Jauch, Karl-Walter, Wöhling, Dirk, Angele, Martin K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626672/ https://www.ncbi.nlm.nih.gov/pubmed/23497558 http://dx.doi.org/10.1186/2047-1440-2-3 |
Ejemplares similares
-
Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers
por: Pratschke, Sebastian, et al.
Publicado: (2016) -
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
por: Hamilton, Betty K., et al.
Publicado: (2023) -
Editorial: Ex vivo Liver Machine Perfusion
por: Nickkholgh, Arash, et al.
Publicado: (2022) -
Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial
por: Nashan, Björn, et al.
Publicado: (2021) -
Ex-vivo Kidney Machine Perfusion: Therapeutic Potential
por: Zulpaite, Ruta, et al.
Publicado: (2021)